Apr 20, 2020
Genome & Company receives FDA IND clearance for GEN-001, its first anti-cancer microbiome therapeutic
Apr 01, 2020
Global Immune Checkpoint Inhibitors Market Outlook 2022
Mar 30, 2020
Alphamab Oncology, Simcere and 3D Medicines Announce Partnership to Develop and Commercialize Subcutaneous Injectable anti-PD-L1 Antibody for Oncology Indications in Mainland China
Mar 17, 2020
4D Pharma Presents Additional Interim Clinical Data From Combination Study for Lead Oncology Candidate
Mar 03, 2020
Targovax Announces Completed Enrollment in the ONCOS-102 Trial in Anti-PD1 Refractory Melanoma
Feb 27, 2020
$200B+ Cancer Immunotherapy Market Opportunity Insights, 2026 - Cancer Vaccines, Monoclonal Antibodies, Trials of T-Cell Therapies, Pipeline Overview, Competitive Landscape, and More
Feb 25, 2020
KAHR Medical Raises $18 Million in Private Funding Round
Feb 20, 2020
Biocare Medical Launches 7 Novel IVD Antibodies for Clinical Diagnostic and Cancer Research Applications with a Focus on Immuno-Oncology
Feb 18, 2020
Phosplatin Therapeutics Announces Publication in OncoImmunology
Feb 11, 2020
Phosplatin Therapeutics Presents Positive Data from Two Phase I Studies in Metastatic Castrate-Resistant Prostate Cancer Patients at the 2020 Genitourinary Cancers Symposium
Jan 22, 2020
Researchers Say Flu Vaccines May Shrink Tumors and Aid in Treating Cancer
Jan 15, 2020
BerGenBio Meets Efficacy Endpoint For First Stage Of Phase II Trial With AXL Inhibitor Bemcentinib in Combination With Keytruda® in NSCLC Patients Progressing on Immune Checkpoint Inhibitors
Jan 15, 2020
John Theurer Cancer Center Participating in Early-Phase Study of Immunotherapy-Boosting Treatment
Jan 09, 2020
Bolt Biotherapeutics Expands Scientific Advisory Board with Appointment of Dr. Priti Hegde
Jan 08, 2020
Pancreatic Cancer Cells Secrete Signal that Sabotages Immune Attack on Tumors
Jan 07, 2020
Innovent and Sirnaomics Entered Strategic Collaboration to Conduct Clinical Oncology Studies Combining Sintilimab and RNAi in the US
Jan 07, 2020
Curis Announces Option and License Agreement with ImmuNext for the Development and Commercialization of Anti-VISTA Antibodies
Jan 07, 2020
Beta Lifescience Announces the Online Availability of Quality Immune Checkpoint Proteins for Scientific Discoveries
Jan 07, 2020
Sirnaomics and Innovent Entered Strategic Collaboration to Conduct Clinical Oncology Studies Combining STP705 and Sintilimab in the US
Jan 06, 2020
Clinical Update - 4D Announce New Study of MRx0518 in Pancreatic Cancer